ARTICLE | Clinical News
Scotia reports on Foscan
August 2, 2000 7:00 AM UTC
Scotia (LSE:SOH) released a clinical update of its Foscan photodynamic therapy in head and neck cancer, reporting that tumor was eliminated in 88 percent of evaluable patients at 12 weeks in a 115-pat...